Fig. 2From: Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiencyAfter 6 months, change in BMI SDS, IGF-1, LDL-C and HDL-C in rhGH treatment group compared with untreated control group. * P<0.05 vs control groupBack to article page